Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression

Journal of Neuro-Oncology

Volumn 73, Issue 3, 2005, Pages 189-198

  Bandrés Elizalde, Eva ^a   Andion, Esther ^a   Escalada, Alvaro ^a   Honorato, Beatriz ^a   Catalan, Victoria ^a   Cubedo, Elena ^a   Cordeu, Lucia ^a   Garcia, Fermin ^a   Zarate, Ruth ^a   Zabalegui, Natalia ^a   Garcia Foncillas, Jesus ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

BCNU; Gene expression profile; Glioma cell lines; MGMT; Microarray

Indexed keywords

CARMUSTINE; DNA DIRECTED RNA POLYMERASE III; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; CELL SURVIVAL; CHROMATIN; CHRONOTHERAPY; DNA ALKYLATION; DNA MICROARRAY; DRUG MECHANISM; DRUG SENSITIVITY; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 22144488783     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-5174-5     Document Type: Article

References (28)

1. MD Walker SB Green DP Byar E Alexander Jr U Batzdorf WH Brooks WE Hunt CS MacCarty MS Mahaley Jr J Mealey Jr G Owens J Ransohoff II JT Robertson WR Shapiro KR Smith Jr CB Wilson TA Strike 1980 Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 30 1323-1329
2. CH Chang J Horton D Schoenfeld O Salazer R Perez Tamayo S Kramer A Weinstein SJ Nelson Y Tsukada 1983 Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study Cancer 52 997-1007
3. CL Nutt M Noble AF Chambers JG Cairncross 2000 Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy Cancer Res 60 4812-4818 1:CAS:528:DC%2BD3cXmsFWhs7s%3D 10987291
4. ME Dolan CD Corsico AE Pegg 1985 Exposure of HeLa cells to 0(6)-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents Biochem Biophys Res Commun 132 178-185 10.1016/ 0006-291X(85)91004-6 1:CAS:528:DyaL28XhtVCjtr8%3D 4062928
5. AE Pegg 1990 Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents Cancer Res 50 6119-6129
6. M Belanich M Pastor T Randall D Guerra J Kibitel L Alas B Li M Citron P Wasserman A White H Eyre K Jaeckle S Schulman D Rector M Prados S Coons W Shapiro D Yarosh 1996 Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine Cancer Res 56 783-788 1:CAS:528:DyaK28XhtVClsLc%3D 8631014
7. KA Jaeckle HJ Eyre JJ Townsend S Schulman HM Knudson M Belanich DB Yarosh SI Bearman DJ Giroux SC Schold 1998 Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: A Southwest Oncology Group study J Clin Oncol 16 3310-3315 1:CAS:528:DyaK1cXmvFGrtbw%3D 9779706
8. JR Silber A Blank MS Bobola S Ghatan DD Kolstoe MS Berger 1999 O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: Frequency and time to tumor progression after alkylating agent-based chemotherapy Clin Cancer Res 5 807-814 1:CAS:528:DyaK1MXislOnsLY%3D 10213216
9. M Esteller J Garcia-Foncillas E Andion SN Goodman OF Hidalgo V Vanaclocha SB Baylin JG Herman 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343 1350-1354 10.1056/NEJM200011093431901 1:CAS:528:DC%2BD3cXosFOltLg%3D 11070098
10. M Schena D Shalon R Heller A Chai PO Brown RW Davis 1996 Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes Proc Natl Acad Sci USA 93 10614-10619 10.1073/pnas.93.20.10614 1:CAS:528:DyaK28XmtVOlsbo%3D 8855227
11. J DeRisi L Penland PO Brown ML Bittner PS Meltzer M Ray Y Chen YA Su JM Trent 1996 Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 14 457-460 10.1038/ng1296-457 1:CAS:528:DyaK28XntlGgtLo%3D 8944026
12. RA Heller M Schena A Chai D Shalon T Bedilion J Gilmore DE Woolley RW Davis 1997 Discovery and analysis of inflammatory disease-related genes using cDNA microarrays Proc Natl Acad Sci USA 94 2150-2155 10.1073/ pnas.94.6.2150 1:CAS:528:DyaK2sXhvF2lt70%3D 9122163
13. DJ Lockhart H Dong MC Byrne MT Follettie MV Gallo MS Chee M Mittmann C Wang M Kobayashi H Horton EL Brown 1996 Expression monitoring by hybridization to high-density oligonucleotide arrays Nat Biotechnol 14 1675-1680 10.1038/nbt1296-1675 1:CAS:528:DyaK28XnsV2ktLo%3D 9634850
14. M Weller J Rieger C Grimmel EG Van Meir N De Tribolet S Krajewski JC Reed A Deimling von J Dichgans 1998 Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses Int J Cancer 79 640-644 10.1002/ (SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z 1:CAS:528:DyaK1MXltlc%3D 9842975
15. A Gomi S Shinoda R Sakai H Hirai K Ozawa T Masuzawa 1996 Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea Biochem Biophys Res Commun 227 558-563 10.1006/bbrc.1996.1545 1:CAS:528:DyaK28Xmt1Kgu7s%3D 8878552
16. B Ma N Hernandez 2001 A map of protein-protein contacts within the small nuclear RNA-activating protein complex SNAPc J Biol Chem 276 5027-5035 10.1074/jbc.M009301200 1:CAS:528:DC%2BD3MXhtlOqu74%3D 11056176
17. H Han DJ Bearss LW Browne R Calaluce RB Nagle DD Von Hoff 2002 Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray Cancer Res 62 2890-2896 1:CAS:528:DC%2BD38XjvFSmt7c%3D 12019169
18. I Takemasa H Higuchi H Yamamoto M Sekimoto N Tomita S Nakamori R Matoba M Monden K Matsubara 2001 Construction of preferential cDNA microarray specialized for human colorectal carcinoma: Molecular sketch of colorectal cancer Biochem Biophys Res Commun, 285 1244-1249
19. J Xu JA Stolk X Zhang SJ Silva RL Houghton M Matsumura TS Vedvick KB Leslie R Badaro SG Reed 2002 Identification of differentially expressed genes in human prostate cancer using subtraction and microarray Cancer Res 60 1677-1682
20. K Kudoh M Ramanna R Ravatn AG Elkahloun ML Bittner PS Meltzer JM Trent WS Dalton KV Chin 2000 Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray Cancer Res 60 4161-4166 1:CAS:528:DC%2BD3cXlvFOkt7g%3D 10945624
21. H Zembutsu Y Ohnishi T Tsunoda Y Furukawa T Katagiri Y Ueyama N Tamaoki T Nomura O Kitahara R Yanagawa K Hirata Y Nakamura 2002 Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs Cancer Res 62 518-527 1:CAS:528:DC%2BD38XhtVyht7c%3D 11809704
22. J Okutsu T Tsunoda Y Kaneta T Katagiri O Kitahara H Zembutsu R Yanagawa S Miyawaki K Kuriyama N Kubota Y Kimura K Kubo F Yagasaki T Higa H Taguchi T Tobita H Akiyama A Takeshita YH Wang T Motoji R Ohno Y Nakamura 2002 Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis Mol Cancer Ther 1 1035-1042 1:CAS:528:DC%2BD3sXmtFantg%3D%3D 12481426
23. BA Teicher 1997 Antitumor alkylating agents In: VT De Vita Jr S Hellman SA Rosenberg (eds) Cancer: Principles and Practice of Oncology 5 Lippincott-Raven Philadelphia 405-418 Vol 1
24. M Colvin J Hilton 1981 Pharmacology of cyclophosphamide and metabolites Cancer Treat 65 (Suppl 3) 65 89-95 1:CAS:528:DyaL38XlslCht78%3D
25. DB Ludlum 1990 DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal Mutat Res 233 117-126 1:CAS:528:DyaK3MXhvFSjtw%3D%3D 2233793
26. AE Pegg ME Dolan RC Moschel 1995 Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase Prog Nucleic Acid Res Mol Biol 51 167-223 1:CAS:528:DyaK2MXos1ertL0%3D 7659775
27. M Purrello C Di Pietro A Rapisarda V Amico V Giunta H Engel S Stevens Y Hsieh M Teichman Z Wang G Sichel R Roeder KH Grzeschik 2001 Genes for human general transcription initiation factors TFIIIB, TFIIIB-associated proteins, TFIIIC2 and PTF/SNAPC: Functional and positional candidates for tumour predisposition or inherited genetic diseases? Oncogene 20 4877-4883 10.1038/sj.onc.1204604 1:CAS:528:DC%2BD3MXmtlCrsbw%3D 11521199
28. HZ Ring V Vameghi-Meyers W Wang GR Crabtree U Francke 1998 Five SWI/ SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome Genomics 51 140-143 10.1006/geno.1998.5343 1:CAS:528:DyaK1cXltFentbo%3D 9693044